The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
88256842 8825684 2 F 201106 20160909 20121004 20160916 EXP US-ASTRAZENECA-2012SE74648 ASTRAZENECA 832.00 MON M Y 87.50000 KG 20160917 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
88256842 8825684 1 PS CRESTOR ROSUVASTATIN CALCIUM 1 Oral U 21366 TABLET
88256842 8825684 2 SS SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Respiratory (inhalation) 160/4.5 MCG 2 PUFFS TWICE DAILY 0
88256842 8825684 3 SS OMEPRAZOLE. OMEPRAZOLE 1 Oral 0 40 MG BID
88256842 8825684 4 C ROPINIROLE. ROPINIROLE 1 Oral 0 TABLET
88256842 8825684 5 C CLOPIDOGREL CLOPIDOGREL BISULFATE 1 Oral 0 75 MG TABLET QD
88256842 8825684 6 C MONTELUKAST MONTELUKAST SODIUM 1 Oral 10.0MG UNKNOWN 0 10 MG TABLET
88256842 8825684 7 C GABAPENTIN. GABAPENTIN 1 Oral 800.0MG UNKNOWN 0 800 MG TABLET
88256842 8825684 8 C LYRICA PREGABALIN 1 Oral 0 TABLET
88256842 8825684 9 C RANEXA RANOLAZINE 1 Oral 0 TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
88256842 8825684 2 Dyspnoea
88256842 8825684 3 Gastrooesophageal reflux disease
88256842 8825684 4 Tremor
88256842 8825684 6 Hypertension
88256842 8825684 7 Neuropathy peripheral
88256842 8825684 8 Burning sensation
88256842 8825684 9 Dyspnoea

Outcome of event

Event ID CASEID OUTC COD
88256842 8825684 HO
88256842 8825684 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
88256842 8825684 Blood pressure decreased
88256842 8825684 Body height decreased
88256842 8825684 Cataract
88256842 8825684 Cerebrovascular accident
88256842 8825684 Coma
88256842 8825684 Fall
88256842 8825684 Fungal infection
88256842 8825684 Gastrooesophageal reflux disease
88256842 8825684 Glaucoma
88256842 8825684 H1N1 influenza
88256842 8825684 Haemorrhoids
88256842 8825684 Hernia
88256842 8825684 Hiatus hernia
88256842 8825684 Increased tendency to bruise
88256842 8825684 Insomnia
88256842 8825684 Lung disorder
88256842 8825684 Myocardial infarction
88256842 8825684 Neuropathy peripheral
88256842 8825684 Parkinsonism
88256842 8825684 Pneumonia
88256842 8825684 Polyp
88256842 8825684 Pruritus
88256842 8825684 Pulmonary mass
88256842 8825684 Rash generalised
88256842 8825684 Rectal discharge
88256842 8825684 Road traffic accident
88256842 8825684 Skin mass
88256842 8825684 Tremor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
88256842 8825684 6 2001 0